PI – Dr. Francis Riedo
Goal: To study the safety and effectiveness of different drugs in treating COVID-19 in outpatients.
For more information: contact EvergreenHealth Research Services at 425.899.5385 or email EvergreenResearch@evergreenhealth.com.
PI – Dr. Diego Lopez de Castilla
Goal: To evaluate the clinical efficacy of baricitinib + remdesivir versus dexamethasone + remdesivir as assessed by the mechanical ventilation free survival by Day 29.
For more information: contact EvergreenHealth Research Services at 425.899.5385 or email EvergreenResearch@evergreenhealth.com.
Protocol #: CRSPTL-00012
PI – Dr. Diego Lopez de Castilla
Goal: Procure plasma and/or serum and other sample types from up to approximately 5,000 study subjects diagnosed positive for acute or chronic tropical or infectious diseases to evaluate the performance of new investigational devices or therapeutics.
For more information: contact EvergreenHealth Research Services at 425.899.5385 or email EvergreenResearch@evergreenhealth.com.